How to Get ASCEND Blend Prescribed Online, Step by Step

ASCEND combines three peptides that prompt the pituitary to release growth hormone with IGF-1 LR3, a modified form of the growth factor growth hormone works through. That shapes the intake.

Bloodwork is not required for any Pepti treatment. If your physician wants labs for your care, they'll ask through your account.

The free assessment asks what you are hoping for and narrows the options. It also confirms availability for your state before you pay. Pepti does not currently serve Oklahoma.

Answer fully. The intake is how a physician rules things out, and for a four-component blend the cautions above are the ones that matter. A prescriber working from an incomplete history makes worse decisions.

A physician licensed in your state reviews your intake, usually within 24 hours. They may prescribe ASCEND, ask a question, suggest something simpler, or decline. The live reference notes that being declined is refunded.

Why you might be offered something simpler

These come from the alternatives described in the live ASCEND reference.

The prescription, written for you by name, goes to a PCAB-accredited, FDA-registered US 503A compounding pharmacy, which prepares the four peptides together in one sterile 5 mL vial at fixed strengths. Lot results for sterility, endotoxin and potency are published at /quality/lab-results.

The vial ships refrigerated in insulated packaging with ice packs, with sterile syringes and alcohol prep pads. It is a ready-to-use solution; there is nothing to reconstitute.

The typical printed direction is: inject 0.25 mL (25 units) subcutaneously Monday through Friday nights at bedtime. Your own directions are set by your physician after reviewing your intake and are the ones that apply.

Because the four are in fixed proportion, every draw delivers the same split. At 0.25 mL five nights a week the vial holds 20 doses, about four weeks. Bedtime is specified because the body's largest growth hormone pulse occurs in the first hours of sleep. Subcutaneous means into the fat layer, usually the abdomen or thigh, with sites rotated. If your directions and syringe markings appear to disagree, message your care team before dosing. More on units is in how long does a peptide vial last, and on this vial in ASCEND Blend dosage.

Storage

Refrigerated, out of light, never frozen. Beyond-use dating is on the label.

Refills run every 28 days, one vial per fill, until you cancel. What gets reported with ASCEND is mostly injection-site redness or soreness, a brief flush, headache and hunger after the dose; ASCEND Blend side effects covers the rest. Message your care team about anything that does not settle. Any reaction that is severe, spreading or involves difficulty breathing needs emergency care: call 911.

The breakdown is on /cost/ascend-blend.

ASCEND has never been studied as a blend. Tesamorelin has randomized phase 3 trials at doses higher than ASCEND delivers; CJC-1295 and ipamorelin have smaller human pharmacology studies; IGF-1 LR3 has essentially no human clinical studies. ASCEND is not FDA approved, and compounded medications are not FDA approved. The research describes changes in hormone levels and, for tesamorelin, visceral fat in specific trial populations; it does not tell you what to expect for yourself.